Back to results
US 2025/0376458 A1Published application
Compounds and methods for yap/tead modulation and indications therefor
AssigneeOpna Bio SA
InventorSomenath CHOWDHURY
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of Formula (I): or a pharmaceutically acceptable salt, a tautomer, a stereoisomer, or a deuterated analog thereof, wherein ring A, ring B, Q, G, R2, R3, R4, R21, p, q, v, Y1, and Y2 are as described in any of the embodiments described in this disclosure; compositions thereof, and uses thereof.
Claims35
A compound having Formula (I):
- or a pharmaceutically acceptable salt, a tautomer, a stereoisomer, or a deuterated analog thereof, wherein:
- Y1 is NR24 and Y2 is N;
- or
- Y1 is N and Y2 is NR24;
- R24 is H or C1-C3 alkyl;
- ring A is phenyl or a 5- or 6-membered heteroaryl comprising 1-4 heteroatoms selected from N, O and S;
- ring B is phenyl, cycloalkyl, or a 5- or 6-membered heteroaryl comprising 1-4 heteroatoms selected from N, O and S,
- Q is —O—, —NR20—, —CR22R23—, —CR22R23O—, or —CR22R23NH—;
- wherein R20 is H or alkyl, R22 is H, halogen, hydroxy, C1-C3 alkyl, or C1-C3 alkoxy, R23 is H, halogen, or C1-C3 alkyl, or R22 and R23 together with the carbon atom to which they are attached, form a carbonyl;
- R21 is C1-C6 alkyl optionally substituted with halogen, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, heterocycloalkyl are optionally substituted with —O—C1-C6 alkyl;
- NH2, NH—C1-C6 alkyl, cycloalkyl;
- or C2-C6 alkenyl;
- each G is independently selected from halogen, OH, CN, alkyl optionally substituted with one or more R5, and alkoxy optionally substituted with one or more R5;
- each R2 is independently H, halogen, —C(O)O-alkyl, or C1-C3alkyl optionally substituted with 1-3 halogens, provided that not more than one R2 is —C(O)O-alkyl;
- R3 is H;
- halogen;
- alkenyl optionally substituted with cycloalkyl or heterocycloalkyl;
- heterocycloalkyl optionally substituted with —C(O)-alkyl;
- heterocycloalkenyl optionally substituted with C(O)-alkyl;
- heterocycloalkylalkyl optionally substituted with C(O)-alkyl;
- or heteroaryl optionally substituted with haloalkyl, cycloalkyl, or cycloalkylalkyl;
- R4 is H;
- alkyl;
- cycloalkyl optionally substituted with haloalkyl or —C(O)-alkenyl;
- heterocycloalkyl optionally substituted with —C(O)-alkyl, —C(O)-alkenyl, or —C(O)-cycloalkyl;
- or heterocycloalkylalkyl optionally substituted with —C(O)-alkyl, —C(O)—CH2—OH, or heteroaryl;
- R5 is halogen or OH;
- v is 0, 1, 2, 3, or 4;
- p is 0, 1, 2, 3, or 4;
- and
- q is 0, 1, or 2.
28 more elements
A compound selected from Table 1, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.